KMS Ranitidine Tablet 150mg (Ranitidine Hydrochloride)
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
MFDS item code 201902447 · Approved 2019.04.19
This product's status changed to Expired on 2024.04.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (such as ulcers); improvement of gastric mucosal lesions; prevention of Mendelson syndrome
This medication is used for the treatment of gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. Additionally, it is effective in preventing Mendelson syndrome before surgery and treating ulcers caused by NSAID use. It also helps improve acute exacerbations of acute and chronic gastritis, acute gastric mucosal damage, and bleeding. It can also be used to relieve heartburn or sour stomach caused by excess stomach acid. Overall, it effectively protects the gastric mucosa and improves symptoms of ulcers and inflammation.
Adults: Administer ranitidine 150 mg orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug 150 mg orally twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The dosage and administration are the same for combination therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Healing usually occurs within 4 weeks; conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. For patients with severe reflux esophagitis, the dose may be increased to 150 mg 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of this drug of 150 mg 3 times daily; the dose may be increased as needed. For severe disease, up to 6 g daily may be administered as directed by a physician. 4) For upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation; once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer this drug 150 mg 2 hours before induction of anesthesia. In this case, it is also preferable to administer 150 mg on the night before surgery. 6) Improvement of gastric mucosal lesions (erosions, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug 150 mg once daily at bedtime. 3. Patients with renal impairment For patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis reduces the plasma concentration of the drug; therefore, readjust the dosing schedule immediately after hemodialysis. Adjust the dose appropriately according to age and symptoms.
Patients aged 12 years and older: Administer 75 mg orally twice daily (for liquid formulation only). Ages 8 〜 18: 150 mg (2 mg per kg of body weight) may be administered up to twice daily.
This medication should not be used in patients who have had allergic reactions to this drug or any of its components. Patients with a history of a rare blood disorder known as acute porphyria may also experience seizures when taking this drug, so it should not be administered. Patients with reduced kidney function may have increased blood concentration of this drug since it is excreted through the kidneys, and dosages may need to be reduced or dosing intervals extended. Patients with impaired liver function should also use this drug with caution. Patients with a history of drug allergies should take it cautiously. Elderly patients may experience decreased bodily functions, so caution is required when administering this medication. Patients taking non-steroidal anti-inflammatory drugs (NSAIDs), especially elderly patients or those with a history of peptic ulcer, should be monitored regularly for their condition. This medication may mask symptoms of gastric cancer, so patients with gastric ulcers or those who have recently developed or changed digestive symptoms should be evaluated to rule out malignancy before use. Patients with gastric or duodenal ulcers infected with Helicobacter pylori should undergo concurrent eradication therapy. This drug can rarely cause severe allergic reactions such as anaphylactic shock, so if symptoms such as difficulty breathing, rash, or decreased blood pressure occur during use, the medication should be stopped immediately, and medical assistance should be sought. If symptoms of hypersensitivity such as hives, rash, or bronchospasm occur, use should be discontinued. Blood tests may show decreased white blood cell or platelet counts, so if symptoms such as fatigue, bleeding, or fever occur, tests should be conducted, and the medication may need to be discontinued. Liver dysfunction may occur, so if symptoms such as jaundice, fatigue, or loss of appetite appear, medication should be stopped immediately. Irregular heartbeats may occasionally occur, so caution should be exercised if there are symptoms like dizziness or palpitations. Gastrointestinal symptoms such as constipation, nausea, or abdominal pain may occur, so if symptoms are severe, medical consultation is advised. Dizziness, drowsiness, headache, insomnia, and mental confusion may rarely occur, so elderly patients or those with kidney disease should take caution. Women who are pregnant or may become pregnant should only use this drug when absolutely necessary, as its safety has not been established. Women who are breastfeeding should also take this medication only when necessary, as it can pass into breast milk. For children, safety has not been adequately established, so caution should be exercised when using this medication. Elderly patients may experience increased medication concentrations due to decreased kidney function, so dosage adjustments may be required. This drug may give false-positive results in urine protein tests during blood tests, so care should be taken with testing methods. Severe side effects from overdose are rare, but appropriate treatment such as vomiting or gastric lavage should be received, and blood dialysis may be performed if necessary. Keep out of reach of children, and do not transfer to other containers as it may lead to quality degradation or accidents. This medication may promote bacterial growth in the gastrointestinal tract by reducing stomach acid secretion, so regular examinations including eye checks are necessary for long-term use.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly sealed container to prevent air exposure, and keep it in a cool, dry place at temperatures between 1 and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
KMS Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 336mg
Prescription medication
Ildong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 168mg
Tablet · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 112mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 56mg
Solution · Prescription medication
Hanin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.